Actinogen Medical Ltd
ASX:ACW
Balance Sheet
Balance Sheet Decomposition
Actinogen Medical Ltd
Actinogen Medical Ltd
Balance Sheet
Actinogen Medical Ltd
| Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
3
|
2
|
1
|
1
|
0
|
0
|
1
|
10
|
1
|
2
|
10
|
8
|
5
|
13
|
16
|
8
|
9
|
17
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
4
|
1
|
2
|
6
|
|
| Cash Equivalents |
0
|
0
|
3
|
2
|
0
|
0
|
0
|
0
|
1
|
10
|
1
|
2
|
10
|
8
|
4
|
7
|
12
|
7
|
7
|
10
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
4
|
5
|
3
|
2
|
4
|
4
|
9
|
6
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
4
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
3
|
2
|
1
|
1
|
0
|
0
|
1
|
10
|
8
|
5
|
13
|
13
|
8
|
15
|
20
|
13
|
19
|
22
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
5
|
5
|
4
|
4
|
3
|
3
|
3
|
2
|
2
|
2
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+440%
|
3
+989%
|
2
-32%
|
1
-33%
|
1
-15%
|
0
-59%
|
0
-40%
|
1
+350%
|
16
+1 136%
|
13
-17%
|
10
-21%
|
18
+77%
|
16
-10%
|
12
-26%
|
18
+54%
|
23
+27%
|
15
-35%
|
21
+40%
|
24
+15%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+100%
|
0
+33%
|
0
+38%
|
0
+55%
|
0
-47%
|
0
+33%
|
0
-33%
|
0
-38%
|
0
+345%
|
1
+270%
|
1
+2%
|
1
-9%
|
1
-27%
|
1
+88%
|
1
-12%
|
2
+70%
|
2
+15%
|
2
-10%
|
6
+280%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
1
|
1
|
4
|
4
|
4
|
5
|
6
|
6
|
7
|
26
|
26
|
27
|
40
|
48
|
48
|
60
|
77
|
79
|
100
|
116
|
|
| Retained Earnings |
0
|
1
|
1
|
2
|
3
|
4
|
5
|
6
|
6
|
11
|
14
|
17
|
23
|
32
|
37
|
43
|
55
|
65
|
80
|
97
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
+950%
|
3
+1 262%
|
2
-34%
|
1
-38%
|
1
-10%
|
0
-67%
|
0
-46%
|
1
+537%
|
15
+1 169%
|
12
-21%
|
9
-23%
|
17
+84%
|
16
-9%
|
11
-30%
|
17
+60%
|
22
+25%
|
13
-38%
|
20
+47%
|
18
-7%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+440%
|
3
+989%
|
2
-32%
|
1
-33%
|
1
-15%
|
0
-59%
|
0
-40%
|
1
+350%
|
16
+1 136%
|
13
-17%
|
10
-21%
|
18
+77%
|
16
-10%
|
12
-26%
|
18
+54%
|
23
+27%
|
15
-35%
|
21
+40%
|
24
+15%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
15
|
18
|
23
|
23
|
23
|
25
|
44
|
45
|
203
|
606
|
619
|
633
|
960
|
1 142
|
1 186
|
1 483
|
1 813
|
1 917
|
2 720
|
3 177
|
|